To validate the role of PTEN in celecoxib-mediated stemness inhibition, PTEN knockdown was performed using PTEN siRNA, which significantly increased the expression of CD133 and CD44 (Fig. 7A), and enhanced the cancer stemness in hepatoma cells in HCC cells (Fig. 7B). This evidence concerns the gene CD44 and cancer.